Please use this identifier to cite or link to this item: http://ktisis.cut.ac.cy/handle/10488/10537
Title: Living with the Effects of Cutaneous Toxicities Induced by Treatment
Authors: Charalambous, Andreas 
Keywords: Cutaneous toxicities;Quality of life;Targeted therapies
Category: Other Medical Sciences
Field: Medical and Health Sciences
Issue Date: 2017
Publisher: MEDKNOW PUBLICATIONS & MEDIA PVT LTD
Source: ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, Volume: 4, Issue: 3, Pages: 220-223, Published: JUL-SEP 2017
metadata.dc.doi: http://dx.doi.org/10.4103/2347-5625.207729
Journal: Asia-Pacific journal of oncology nursing
Abstract: The introduction of targeted therapies in cancer treatment was accompanied with promising results including tumor control and patients survival benefits. However, these drugs just like their predecessors were associated with systemic side effects, including frequent and various cutaneous effects. Targeted therapies such as epidermal growth factor receptor, vascular endothelial growth factor receptor, kit, platelet-derived growth factor receptor, and BCR-ABL inhibitors as well as mammalian target of rapamycin inhibitors can induce cutaneous toxicities of varying severity. There are scarce studies on the actual impact of these toxicities on the patients' lives including the physical, social, and psychological aspects and overall quality of life. Patient's perspective in living with and beyond these toxicities remains largely uncharted but essential in optimizing care provided to those receiving treatment with targeted therapies.
URI: http://ktisis.cut.ac.cy/handle/10488/10537
ISSN: 2347-5625
Rights: © 2017, Wolters Kluwer Medknow Publications
Type: Article
Appears in Collections:Άρθρα/Articles

Show full item record

Page view(s)

12
Last Week
2
Last month
checked on Dec 13, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.